Shop by goal
Popular compounds
Research resources
Recently viewed
Peptides in Culture & the Press
What the press reports about peptides - celebrities, longevity clinics and the protocols behind the headlines, every quote attributed and carrying no endorsement.
13 articles tagged “Culture & Press”
TikTok Peptide Sellers: How to Spot Hype, Resellers and Quick-Buck Marketing
Viral peptide videos do not equal credible suppliers. How to see past parcels, luxury cars and "selling out fast" urgency - reselling, affiliate links and follower counts - and the evidence-based questions (independent testing, CoAs, transparency) to ask a research-compound supplier instead. Research use only.
The Unregulated Peptide Grey Market: What the Telegraph Investigation Reveals
A Telegraph investigation describes men and women self-injecting unregulated peptides bought from influencers and grey-market sellers. What the report found, why "research use only" is a legal line and not a green light for human use, and why third-party purity testing matters. Research use only.
Trump, Retatrutide and the Obesity-Drug Demand Story
The White House denies that Donald Trump got early compassionate-use access to retatrutide, an experimental obesity drug still in Eli Lilly trials. What the story says, what compassionate use is, why retatrutide is not approved before 2027, and why research use only is a separate category from human use.
Why Reta Searches Are Surging in the USA: A 2026 Search-Trend Report
US search interest in retatrutide ("reta", LY3437943) has gone from near-zero to a Google Trends Breakout term since 2023. What is driving the surge, what the data does and does not mean, and how US researchers source it. Search-interest data only - research use only.
The Rising Demand for Research Peptides in the UK: A 2026 Search-Trend Report
UK search interest in research peptides - GLP-1 compounds, BPC-157, GHK-Cu and more - has climbed sharply since 2023. What UK researchers search for, why, the MHRA framing, and how the research-use market works. Search-interest data only - research use only.
Research Peptide Search Demand in the USA: A 2026 Trend Report
US search interest in research peptides surged through the GLP-1 era and the FDA compounding shake-up. What American researchers search for, why, the FDA framing, and how the research-use market works. Search-interest data only - research use only.
Peptide Search Demand in Australia: A 2026 Trend Report
Australian search interest in research peptides has climbed sharply, led by GLP-1 compounds. What Australian researchers search for, why, the TGA framing, and how the research-use market works. Search-interest data only - research use only.
Is Retatrutide Safe? What the Research and the Safety Warnings Actually Show
After 2026 news reports of retatrutide ("reta") being sold online despite its unapproved status, what the research actually shows on safety: the Phase 2 adverse-event picture (dose-dependent GI effects, a heart-rate signal), the long-term unknowns, why self-sourcing is the real risk, and the research-use-only line.
GLP-1 Access Is Becoming a Coverage Problem
With Cigna dropping GLP-1 obesity coverage for its own plan, access and affordability are now separate from the science. A neutral look at the market shift.
Why peptides could become the next big mainstream health news story
Peptides such as BPC-157, TB-500, Semax and Epitalon are moving from niche research circles into mainstream health news as the FDA prepares its July 2026 compounding review. Why it matters - and how to read the coverage responsibly, because a review is not an approval.
Peptides, the FDA and the media: what viewers need to understand
As peptides become a bigger public-health story around the FDA's July 2026 review, audiences need clearer information about BPC-157, TB-500, Semax, Epitalon and the 503A Bulks List. A plain-English guide to reading the coverage - FDA review is not FDA approval.
What peptides do celebrities use? A press-sourced roundup
The cited version - BPC-157, NAD+, the “Wolverine stack” - with every quote attributed to ELLE, TIME, The Times, Yahoo and AOL. Reporting on press coverage, not endorsement.
Inside the private clinics: protocols of the top 1%
The compounds Silicon Valley founders and A-list actors have cycled through for over a decade in $30,000-a-year longevity clinics - and how direct-to-researcher access changes the equation.
Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.
Browse the full catalogue
Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.
Shop
Learn
Company
Support
Ways to Pay
Shop by Compound
Shop by Goal
Ships worldwide
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io · @new.u.io